Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Apr 21, 2017; 23(15): 2757-2762
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2757
Table 1 Clinical characteristics of the entire patient cohort1n (%)
CharacteristicEntire cohortStage IBStage IIAP value
Number of patients1349886463
Age (yr), median (range)65 (18-90)65 (18-90)63 (18-90)0.000
Tumor size (mm), mean (range)43.4 (21-540)29.5 (21-40)70.0 (41-540)0.000
Gender
Male626 (46.40)405 (45.71)221 (47.73)0.480
Female723 (53.60)481 (54.29)242 (52.27)
Primary site
Head633 (46.9)486 (54.85)147 (31.75)0.000
Body165 (12.23)103 (11.6)62 (13.39)
Tail350 (25.95)186 (20.99)164 (35.21)
Other201 (14.90)111 (12.53)90 (19.44)
Grade
I348 (25.80)221 (24.94)127 (27.43)0.006
II484 (35.88)335 (37.81)149 (32.18)
III230 (17.05)164 (18.52)66 (14.25)
IV17 (1.26)10 (1.13)7 (1.51)
Unknown270 (20.01)156 (17.61)114 (24.62)
Race
White1060 (78.58)694 (78.33)366 (79.05)0.760
Other289 (21.42)192 (21.67)97 (20.95)
Table 2 Prognostic significance for overall survival by univariate analysis of variables for stage IB and IIA patients1
VariableStage IB
Stage IIA
nLog-ranknLog-rank
Age (yr)
≤ 654440.0002700.000
> 65442193
Gender
Male4050.1622210.002
Female481242
Tumor size (mm)
21-305840.258
31-40302
41-703320.013
> 70131
Primary site
Head4860.0001470.004
Body10362
Tail186164
Other11190
Grade
I2210.0001270.000
II335149
III16466
IV107
Unknown156114
Race
White6940.1483660.685
Other19297
Table 3 Prognostic significance for overall survival by multivariate analysis of variables for stage IB and IIA patients1
VariableStage IB
Stage IIA
RR95%CIP valueRR95%CIP value
Age1.0371.025-1.0490.0001.0451.029-1.0620.000
Gender (male vs female)1.1280.887-1.4340.3271.2350.852-1.7900.265
Tumor size1.0180.996-1.0390.0001.0030.999-1.0080.173
Primary site (head vs body-tail)1.7341.311-2.2940.0001.1970.825-1.7360.345
Grade (I + II vs III + IV)0.5700.443-0.7340.1040.4900.333-0.7210.000